Investors are in the midst of reporting season and there are many numbers to crunch to gauge the health of their portfolios.
If it's all too overwhelming, I have filtered out the noise to pick out the most impressive digits I have seen out of ASX shares this week:
252%: GUD Holdings
On the close of Monday, automotive and swimming pool product maker GUD Holdings Limited (ASX: GUD) had already seen its share price rocket 36% so far this year.
But then its annual results on Tuesday sent it soaring a further 15% that day.
And it's no wonder, with GUD Holdings reporting a massive 251.8% boost in statutory net profit after tax (NPAT), which reached $98.6 million.
The company is in the process of selling its water business to focus on executing as a pure automotive player.
84%: Origin
Amid rising power bills, Origin Energy Ltd (ASX: ORG) raked in an underlying profit of $747 million, which was 84% up from the previous financial year.
"Operational performance right across Origin was strong this year with higher earnings contributions from Energy Markets, Integrated Gas, and Octopus Energy in the UK," said chief executive Frank calabria.
"Australia Pacific LNG delivered record revenue and cash distributions to Origin as it benefited from elevated commodity prices."
The Origin share price has now risen 47% over the past 12 months.
37%: Pro Medicus
The classic growth stock that's always derided as "too expensive" is continuing to prove the critics wrong.
On Tuesday, the health tech provider reported a 36.5% NPAT boost for the financial year just completed.
"The trends we have previously identified as driving the industry continue unabated," said Pro Medicus Limited (ASX: PME) chief Dr Sam Hupert.
"Exponentially larger data sets, the transition to cloud and the acute global shortage of radiologists create demands that are uniquely satisfied by our Visage technology."
Pro Medicus shares are now trading 28% higher than where they started this year.
21%: Cochlear
Cochlear Limited (ASX: COH) has made its name as a growth stock, but it had a nice surprise this week against that stereotype.
The company announced a final dividend of $1.75, which is a 21% increase on the prior year.
That's despite statutory net profit only rising by 4%.
The Cochlear share price has soared higher in excess of 27% so far this year.
11%: Magellan Financial Group
The much-maligned Magellan Financial Group Ltd (ASX: MFG) has been a risky buy for a couple of years, but it rocketed on Friday after reporting its results.
The business is in the midst of reforming its costs and funds performance to reverse the chronic outflow it has suffered from recently.
Despite reducing dividends compared to the 2022 financial year, the depressed share price means the dividend yield is at an extremely attractive 11%.
